Welcome to CDC stacks | Implementation and Effectiveness of Antiretroviral Therapy in Greenland - 17017 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Implementation and Effectiveness of Antiretroviral Therapy in Greenland
  • Published Date:
    Jan 2008
  • Source:
    Emerg Infect Dis. 14(1):56-59.
Filetype[PDF-295.94 KB]


Details:
No Related Documents.
You May Also Like:
  1. The Effect of Cotrimoxazole Prophylactic Treatment on Malaria, Birth Outcomes, and Postpartum CD4 Count in HIV-Infected Women
    Personal Author:
    Dow, Anna; Kayira, Dumbani; Hudgens, Michael G.; Van Rie, Annelies; King, Caroline C.; Ellington, Sascha; Chome, Nelecy; Kourtis, Athena; Turner, Abigail Norris; Kacheche, Zebrone; Jamieson, Denise J.; Chasela, Charles; van der Horst, Charles;
    Published:
    Dec 05 2013
    Source:
    Infect Dis Obstet Gynecol. 2013; 2013.
    Description:
    Limited data exist on cotrimoxazole prophylactic treatment (CPT) in pregnant women, including protection against malaria versus standard intermittent preventive therapy with sulfadoxine-pyrimethamine (IPTp).|Using observational data we examined the e...
    File Type:
    Filetype[PDF - 701.28 KB]
  2. The Effects of Cotrimoxazole Prophylactic Treatment on Adverse Health Outcomes among Human Immunodeficiency Virus-Exposed, Uninfected Infants
    Personal Author:
    Dow, Anna; Kayira, Dumbani; Hudgens, Michael; Van Rie, Annelies; King, Caroline C.; Ellington, Sascha; Kourtis, Athena; Turner, Abigail Norris; Meshnick, Steven; Kacheche, Zebrone; Jamieson, Denise J.; Chasela, Charles; van der Horst, Charles;
    Published:
    Aug 2012
    Source:
    Pediatr Infect Dis J. 31(8):842-847.
    Description:
    Background : The World Health Organization guidelines recommend cotrimoxazole prophylactic treatment (CPT) for all HIV-exposed infants from age 6 weeks to the cessation of breastfeeding and the exclusion of HIV infection. There are limited data about...
    File Type:
    Filetype[PDF - 385.94 KB]
  3. Decentralization Does Not Assure Optimal Delivery of PMTCT and HIV-Exposed Infant Services in a Low Prevalence Setting
    Personal Author:
    Edmonds, Andrew; Feinstein, Lydia; Okitolonda, Vitus; Thompson, Deidre; Kawende, Bienvenu; Behets, Frieda;
    Published:
    Dec 01 2015
    Source:
    J Acquir Immune Defic Syndr. 70(4):e130-e139
    Description:
    Background : The consequences of decentralizing prevention of mother-to-child HIV transmission and HIV-exposed infant services to antenatal care (ANC)/labor and delivery (L&D) sites from dedicated HIV care and treatment (C&T) centers remain unknown, ...
    File Type:
    Filetype[PDF - 275.04 KB]
  4. Quantification of CD4 Responses to Combined Antiretroviral Therapy Over 5 Years Among HIV-Infected Children in Kinshasa, Democratic Republic of Congo
    Personal Author:
    Edmonds, Andrew; Yotebieng, Marcel; Lusiama, Jean; Matumona, Yori; Kitetele, Faustin; Nku, David; Napravnik, Sonia; Cole, Stephen R.; Van Rie, Annelies; Behets, Frieda;
    Published:
    Sep 01 2012
    Source:
    J Acquir Immune Defic Syndr. 61(1):90-98
    Description:
    Background : The long-term effects of combined antiretroviral therapy (cART) on CD4 percentage in HIV-infected children are incompletely understood, with evidence from resource-deprived areas particularly scarce even though most children with HIV liv...
    File Type:
    Filetype[PDF - 565.25 KB]
  5. Isoniazid Preventive Therapy and Risk for Resistant Tuberculosis
    Personal Author:
    Balcells, Maria Elvira; Thomas, Sara L.; Godfrey-Faussett, Peter; Grant, Alison D.;
    Published:
    May 2006
    Source:
    Emerg Infect Dis. 12(5):744-751.
    Description:
    In the context of tuberculosis (TB) resurgence, isoniazid preventive therapy (IPT) is increasingly promoted, but concerns about the risk for development of isoniazid-resistant tuberculosis may hinder its widespread implementation. We conducted a syst...
    File Type:
    Filetype[PDF - 223.08 KB]